Provided by Tiger Trade Technology Pte. Ltd.

NeoGenomics

16.34
-0.6400-3.77%
Volume:719.54K
Turnover:11.89M
Market Cap:2.09B
PE:-40.62
High:16.80
Open:16.75
Low:16.28
Close:16.98
52wk High:17.08
52wk Low:6.38
Shares:128.00M
Float Shares:117.00M
Volume Ratio:0.50
T/O Rate:0.61%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4023
EPS(LYR):-0.8433
ROE:-6.33%
ROA:-1.89%
PB:2.66
PE(LYR):-19.38

Loading ...

Leerink Upgrades NeoGenomics to Outperform From Market Perform, Adjusts Price Target to $25 From $12

MT Newswires Live
·
Apr 29

Neogenomics Inc : Benchmark Raises to Buy From Hold

THOMSON REUTERS
·
Apr 29

NeoGenomics upgraded to Outperform from Market Perform at Leerink

TIPRANKS
·
Apr 29

Analysts Are Bullish on These Healthcare Stocks: Telix Pharmaceuticals (TLPPF), NeoGenomics (NEO)

TIPRANKS
·
Apr 29

NeoGenomics reports Q1 adjusted EPS 1c, consensus 0c

TIPRANKS
·
Apr 29

NeoGenomics raises FY26 revenue view to $797M-$803M from $793M-$801M

TIPRANKS
·
Apr 29

GUIDANCE: (NEO) NeoGenomics Expects Full Year 2026 Revenue Range $797 Million - $803 Million, vs. FactSet Est of $796.7 Million

MT Newswires Live
·
Apr 29

Neogenomics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
Apr 29

NeoGenomics Q1 net loss narrows 34% to $17 million; revenue rises 11% to $187 million

Reuters
·
Apr 29

NeoGenomics Q1 Adj. EPS $0.01, Inline, Sales $186.672M Beat $184.509M Estimate

Benzinga Earnings
·
Apr 29

BRIEF-NeoGenomics Q1 Revenue USD 187 Million Vs. IBES Estimate USD 184.5 Million

Reuters
·
Apr 29

Neogenomics Outlook FY Revenue USD 797-803 Million

THOMSON REUTERS
·
Apr 29

Neogenomics Q1 Gross Profit USD 81 Million

THOMSON REUTERS
·
Apr 29

Neogenomics Q1 Operating Expenses USD 99 Million

THOMSON REUTERS
·
Apr 29

Neogenomics Q1 Revenue USD 187 Million VS. Ibes Estimate USD 184.5 Million

THOMSON REUTERS
·
Apr 29

Neogenomics Q1 EPS USD -0.13

THOMSON REUTERS
·
Apr 29

A Look At NeoGenomics (NEO) Valuation After Recent Share Price Rebound And Ongoing Weak Returns

Simply Wall St.
·
Apr 28

Volaris Reports Financial Results for the First Quarter 2026

GlobeNewswire
·
Apr 28

NeoGenomics expands oncology test ordering through Epic Aura EHR integration

Reuters
·
Apr 23

Earning Preview: NeoGenomics this quarter’s revenue is expected to increase by 7.94%, and institutional views are bullish

Earnings Agent
·
Apr 22